INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.450
+0.150 (11.54%)
At close: Jun 18, 2026, 4:00 PM EDT
1.410
-0.040 (-2.74%)
After-hours: Jun 18, 2026, 7:46 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $38.55 million as of June 18, 2026. Its market cap has decreased by -78.23% in one year.
Market Cap
38.55M
Enterprise Value
18.70M
1-Year Change
-78.23%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $38.55M, a decrease of -50.47%. That is a compound annual growth rate of -9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 38.55M | -7.05% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 37.20M |
| CervoMed | 35.28M |
| ABVC BioPharma | 34.37M |
| Grace Therapeutics | 34.35M |
| GridAI Technologies | 33.33M |
| Aligos Therapeutics | 33.11M |
| Lisata Therapeutics | 32.05M |
| Actinium Pharmaceuticals | 32.00M |